Dr. Lawrence Brandt on Fecal Microbiota Transplant Part II

Lawrence Brandt, MD, professor of medicine and surgery at the Albert Einstein College of Medicine in New York City, discusses the safety of fecal transplant as well as its applications to conditions other than Clostridium difficile colitis. He explains that fecal transplant has an extremely high success rate (90+ percent) in a very short period of time, with no known adverse effects and relatively low cost. Other conditions the procedure may be used to treat include irritable bowel disease, constipation, bloating, ulcerative colitis, Parkinson’s disease, myoclonic dystrophy, autism, and morbid obesity. This video was shot at the annual scientific conference of the American College of Gastroenterology.

This is the second of three videos of our interview with Dr. Brandt. To see the first video click here.